BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31740811)

  • 1. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.
    Kluin-Nelemans HC; Reiter A; Illerhaus A; van Anrooij B; Hartmann K; Span LFR; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; Zink A; Fuchs D; Kilbertus A; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Niederwieser D; Breynaert C; Várkonyi J; Kennedy V; Lortholary O; Jakob T; Hermine O; Rossignol J; Arock M; Gotlib J; Valent P; Sperr WR
    Leukemia; 2020 Apr; 34(4):1090-1101. PubMed ID: 31740811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.
    Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR
    Theranostics; 2021; 11(1):292-303. PubMed ID: 33391475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.
    Trizuljak J; Sperr WR; Nekvindová L; Elberink HO; Gleixner KV; Gorska A; Lange M; Hartmann K; Illerhaus A; Bonifacio M; Perkins C; Elena C; Malcovati L; Fortina AB; Shoumariyeh K; Jawhar M; Zanotti R; Bonadonna P; Caroppo F; Zink A; Triggiani M; Parente R; von Bubnoff N; Yavuz AS; Hägglund H; Mattsson M; Panse J; Jäkel N; Kilbertus A; Hermine O; Arock M; Fuchs D; Sabato V; Brockow K; Bretterklieber A; Niedoszytko M; van Anrooij B; Reiter A; Gotlib J; Kluin-Nelemans HC; Mayer J; Doubek M; Valent P
    Allergy; 2020 Aug; 75(8):1927-1938. PubMed ID: 32108361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.
    Lübke J; Schwaab J; Christen D; Elberink HO; Span B; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Solomianyi O; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Zink A; Brockow K; Breynaert C; Bullens D; Yavuz AS; Doubek M; Sabato V; Schug T; Niederwieser D; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Jawhar M
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):581-590.e5. PubMed ID: 36403897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
    Böhm A; Födinger M; Wimazal F; Haas OA; Mayerhofer M; Sperr WR; Esterbauer H; Valent P
    J Allergy Clin Immunol; 2007 Jul; 120(1):192-9. PubMed ID: 17451799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the blood eosinophil count with hematological malignancies and mortality.
    Andersen CL; Siersma VD; Hasselbalch HC; Vestergaard H; Mesa R; Felding P; Olivarius ND; Bjerrum OW
    Am J Hematol; 2015 Mar; 90(3):225-9. PubMed ID: 25488524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.
    Wilson TM; Maric I; Shukla J; Brown M; Santos C; Simakova O; Khoury P; Fay MP; Kozhich A; Kolbeck R; Metcalfe DD; Klion AD
    J Allergy Clin Immunol; 2011 Nov; 128(5):1086-92.e1-3. PubMed ID: 21762978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil phagocytosis in advanced systemic mastocytosis with eosinophilia.
    Morales-Camacho RM; Villanueva-Herraiz S; Prats-Martín C; Borrero JJ; Bernal R; Vargas MT
    Br J Haematol; 2018 Jun; 181(5):578. PubMed ID: 29602231
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.
    Valent P; Oude Elberink JNG; Gorska A; Lange M; Zanotti R; van Anrooij B; Bonifacio M; Bonadonna P; Gleixner KV; Hadzijusufovic E; Perkins C; Hartmann K; Illerhaus A; Merante S; Elena C; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; David Fuchs ; Greul R; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Al-Ali HK; Morren MA; Varkonyi J; Zink A; Niedoszytko M; Niederwieser D; Malcovati L; Reiter A; Kennedy V; Gotlib J; Lortholary O; Hermine O; Arock M; Kluin-Nelemans H; Sperr WR;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):81-87. PubMed ID: 30416055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mast cell disease presenting with peripheral blood eosinophilia.
    Miranda RN; Esparza AR; Sambandam S; Medeiros LJ
    Hum Pathol; 1994 Jul; 25(7):727-30. PubMed ID: 8026833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models.
    Pardanani A; Shah S; Mannelli F; Elala YC; Guglielmelli P; Lasho TL; Patnaik MM; Gangat N; Ketterling RP; Reichard KK; Hanson CA; Vannucchi AM; Tefferi A
    Blood Adv; 2018 Nov; 2(21):2964-2972. PubMed ID: 30413432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.
    Sperr WR; Kundi M; Alvarez-Twose I; van Anrooij B; Oude Elberink JNG; Gorska A; Niedoszytko M; Gleixner KV; Hadzijusufovic E; Zanotti R; Bonadonna P; Bonifacio M; Perkins C; Illerhaus A; Elena C; Merante S; Shoumariyeh K; von Bubnoff N; Parente R; Jawhar M; Belloni Fortina A; Caroppo F; Brockow K; Zink A; Fuchs D; Kilbertus AJ; Yavuz AS; Doubek M; Hägglund H; Panse J; Sabato V; Bretterklieber A; Niederwieser D; Breynaert C; Hartmann K; Triggiani M; Nedoszytko B; Reiter A; Orfao A; Hermine O; Gotlib J; Arock M; Kluin-Nelemans HC; Valent P
    Lancet Haematol; 2019 Dec; 6(12):e638-e649. PubMed ID: 31676322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
    Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
    Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and prognostic impact of
    Muñoz-González JI; Álvarez-Twose I; Jara-Acevedo M; Henriques A; Viñas E; Prieto C; Sánchez-Muñoz L; Caldas C; Mayado A; Matito A; Dasilva-Freire N; Orfao A; García-Montero AC
    Blood; 2019 Aug; 134(5):456-468. PubMed ID: 31151985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia.
    Ionescu MA; Rivet J; Daneshpouy M; Briere J; Morel P; Janin A
    J Am Acad Dermatol; 2005 Jan; 52(1):32-9. PubMed ID: 15627078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eleven cases of angioedema with eosinophilia treated in a single hospital in Japan.
    Nakachi S; Inokuma S
    Allergol Int; 2012 Jun; 61(2):259-63. PubMed ID: 22361512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy.
    Moreira A; Leisgang W; Schuler G; Heinzerling L
    Immunotherapy; 2017 Jan; 9(2):115-121. PubMed ID: 28128709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophilia and degree of sensitization to house dust mites in preschool and school children with asthma.
    Youroukova VF; Oddera S; Silvestri M; Spallarossa D; Rossi GA
    J Asthma; 1998; 35(6):489-96. PubMed ID: 9751066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population.
    Lou H; Meng Y; Piao Y; Wang C; Zhang L; Bachert C
    Am J Rhinol Allergy; 2015; 29(5):350-6. PubMed ID: 26219765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.